BioCentury | Apr 25, 2020
Deals

Novartis business development stays on course during COVID-19

...other three deals comprised two R&D collaborations with biotechs and a product-specific development deal with Drugs for Neglected Diseases initiative (DNDi)...
BioCentury | Feb 8, 2020
Politics, Policy & Law

GAO finds little evidence Priority Review program spurring drug development

...spoke with academic researchers and other stakeholders, including the Bill and Melinda Gates Foundation, BIO, Drugs for Neglected Diseases Initiative...
BioCentury | Apr 18, 2019
Company News

Three steps forward, one step back for AI drug discovery

...several small molecule hits for an unexploited Chagas disease target through a partnership with the Drugs for Neglected Diseases initiative (DNDi)...
BioCentury | Apr 17, 2019
Preclinical News

Atomwise unveils Chagas disease compounds from AIMS program

...the Drugs for Neglected Diseases initiative (DNDi) announced the discovery of compounds targeting Trypanosoma cruzi , which causes Chagas disease. DNDi...
...machine learning AtomNet platform to hit the targets. Atomwise CEO Abraham Heifets told BioCentury that DNDi...
...with single-digit μM potencies against cruzain, a cysteine protease of T. cruzi . Heifets said DNDi...
BioCentury | Sep 28, 2018
Financial News

Entasis raises $75M in IPO

...III trial next year of a second program, zoliflodacin (ETX0914) to treat uncomplicated gonorrhea. The Drugs for Neglected Diseases initiative...
BioCentury | Sep 26, 2018
Financial News

Entasis dips in first trading day after $75M IPO

...III trial next year of a second program, zoliflodacin (ETX0914) to treat uncomplicated gonorrhea. The Drugs for Neglected Diseases initiative...
BioCentury | Aug 31, 2018
Financial News

Antibacterial company Entasis proposes NASDAQ IPO

...of the compound is slated to begin next year and will be sponsored by the Drugs for Neglected Diseases initiative...
BioCentury | Aug 17, 2018
Financial News

Antibacterial company Entasis proposes NASDAQ IPO

...of the compound is slated to begin next year and will be sponsored by the Drugs for Neglected Diseases initiative...
BioCentury | Mar 9, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a...
...Chile and more than $6,000 in Brazil for a 12-week course of treatment, according to DNDi...
...Laboratorio Elea Phoenix S.A. (Argentina) will register, manufacture and distribute the compounds in Latin America. DNDi...
BioCentury | Mar 7, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a...
...Chile and more than $6,000 in Brazil for a 12-week course of treatment, according to DNDi...
...and Laboratorio Elea Phoenix S.A. will register, manufacture and distribute the compounds in Latin America. DNDi...
Items per page:
1 - 10 of 62
BioCentury | Apr 25, 2020
Deals

Novartis business development stays on course during COVID-19

...other three deals comprised two R&D collaborations with biotechs and a product-specific development deal with Drugs for Neglected Diseases initiative (DNDi)...
BioCentury | Feb 8, 2020
Politics, Policy & Law

GAO finds little evidence Priority Review program spurring drug development

...spoke with academic researchers and other stakeholders, including the Bill and Melinda Gates Foundation, BIO, Drugs for Neglected Diseases Initiative...
BioCentury | Apr 18, 2019
Company News

Three steps forward, one step back for AI drug discovery

...several small molecule hits for an unexploited Chagas disease target through a partnership with the Drugs for Neglected Diseases initiative (DNDi)...
BioCentury | Apr 17, 2019
Preclinical News

Atomwise unveils Chagas disease compounds from AIMS program

...the Drugs for Neglected Diseases initiative (DNDi) announced the discovery of compounds targeting Trypanosoma cruzi , which causes Chagas disease. DNDi...
...machine learning AtomNet platform to hit the targets. Atomwise CEO Abraham Heifets told BioCentury that DNDi...
...with single-digit μM potencies against cruzain, a cysteine protease of T. cruzi . Heifets said DNDi...
BioCentury | Sep 28, 2018
Financial News

Entasis raises $75M in IPO

...III trial next year of a second program, zoliflodacin (ETX0914) to treat uncomplicated gonorrhea. The Drugs for Neglected Diseases initiative...
BioCentury | Sep 26, 2018
Financial News

Entasis dips in first trading day after $75M IPO

...III trial next year of a second program, zoliflodacin (ETX0914) to treat uncomplicated gonorrhea. The Drugs for Neglected Diseases initiative...
BioCentury | Aug 31, 2018
Financial News

Antibacterial company Entasis proposes NASDAQ IPO

...of the compound is slated to begin next year and will be sponsored by the Drugs for Neglected Diseases initiative...
BioCentury | Aug 17, 2018
Financial News

Antibacterial company Entasis proposes NASDAQ IPO

...of the compound is slated to begin next year and will be sponsored by the Drugs for Neglected Diseases initiative...
BioCentury | Mar 9, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a...
...Chile and more than $6,000 in Brazil for a 12-week course of treatment, according to DNDi...
...Laboratorio Elea Phoenix S.A. (Argentina) will register, manufacture and distribute the compounds in Latin America. DNDi...
BioCentury | Mar 7, 2018
Company News

DNDi, partners aim to bring cheaper HCV combo to Latin America

...The Drugs for Neglected Diseases initiative said it will partner with three pharmaceutical companies and a non-profit to sell a...
...Chile and more than $6,000 in Brazil for a 12-week course of treatment, according to DNDi...
...and Laboratorio Elea Phoenix S.A. will register, manufacture and distribute the compounds in Latin America. DNDi...
Items per page:
1 - 10 of 62